Arrowhead Pharmaceuticals Inc (ARWR)

Working capital turnover

		Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Revenue (ttm)	US$ in thousands	829,448	596,565	568,798	26,089	27,140	19,648	35,473	181,740	240,735	256,213	272,800	278,338	243,231	249,939	263,418	144,424	138,288	107,638	89,123	79,841
Total current assets	US$ in thousands	950,639	946,923	1,135,220	570,536	695,471	450,062	541,650	237,899	419,521	470,165	574,810	501,831	376,396	432,388	417,630	338,278	384,597	525,955	586,757	323,716
Total current liabilities	US$ in thousands	195,487	194,530	220,541	93,758	103,168	96,714	65,175	63,723	105,456	70,227	87,151	66,281	74,099	128,212	138,857	137,032	146,536	195,434	167,188	25,094
Working capital turnover		1.10	0.79	0.62	0.05	0.05	0.06	0.07	1.04	0.77	0.64	0.56	0.64	0.80	0.82	0.94	0.72	0.58	0.33	0.21	0.27

September 30, 2025 calculation

Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $829,448K ÷ ($950,639K – $195,487K)
= 1.10